New therapeutics in rheumatoid arthritis.

Published

Journal Article (Review)

Rheumatoid arthritis (RA) is a systemic disorder characterized predominately by a chronic inflammatory polyarthritis, with frequent progression to joint destruction and disability. Radiographic joint damage develops in as many as 75% of patients within the first 2 years of disease. For this reason, current RA treatment approaches have focused on early intensive therapy with multiple disease-modifying antirheumatic drugs. The approval of new drugs for this indication has expanded the number of therapeutic options that can potentially allow for tight control of the inflammatory process.

Full Text

Duke Authors

Cited Authors

  • Savage, C; St Clair, EW

Published Date

  • February 2006

Published In

Volume / Issue

  • 32 / 1

Start / End Page

  • 57 - viii

PubMed ID

  • 16504821

Pubmed Central ID

  • 16504821

International Standard Serial Number (ISSN)

  • 0889-857X

Digital Object Identifier (DOI)

  • 10.1016/j.rdc.2005.10.004

Language

  • eng

Conference Location

  • United States